Svexa, an exercise intelligence startup, combining sports performance, human biology, and data science, announced the acquisition of Zone7, an AI-driven human performance platform. The merger integrates Zone7’s specialized capabilities in injury risk forecasting and load management with Svexa’s robust analytics solutions, according to their press release.
The combined entity aims to create a comprehensive end-to-end AI platform catering to sports, military and wellness applications.
“Together we provide the first end-to-end AI suite to cover the entire human performance journey: young athlete development, performance optimization when ‘going pro’, load management and injury risk mitigation, to athlete career longevity” stated CEO and co-founder of Zone7, Tal Brown, in a linkedin post today.
Svexa’s portfolio already includes collaborations with elite sports teams and leagues across various disciplines such as basketball, soccer, and American football. Similarly, Zone7’s notable clients include high-profile teams like Liverpool FC and SSC Napoli, along with partners in the NFL, MLS, and NWSL.
Founded in 2017 by Eyal Eliakim and Tal Brown, Zone7 raised over $10 million in funding, with its most recent round, $8 million Series A, completed in 2021. Investors in Zone7 include Blumberg Capital, UpWest Labs, Joyance Partners, Resolute Ventures and Alumni Ventures Group, among others. NBA player Kristaps Porzingis is also a shareholder.
As it happens, this is the second portfolio exit for Joyance Partners in the week; Clay was acquired by Kangarootime, announced yesterday.
Svexa’s proprietary algorithms are designed to deliver hyper-personalized, actionable recommendations that optimize individual performance, supported by plug-and-play APIs for easy integration across sports, fitness, and health tech providers. They were founded in 2018 and raised approximately $3 million in funding.
